medigraphic.com
SPANISH

Revista Cubana de Oftalmología

ISSN 1561-3070 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 3

<< Back Next >>

Rev Cub Oftal 2014; 27 (3)

Posterior scleritis: a propos of a case

Ambou FI, Valdés PÁ, de Prada SC, Pérez SL, Carvajal RS
Full text How to cite this article

Language: Spanish
References: 14
Page: 497-502
PDF size: 122.79 Kb.


Key words:

non-steroidal anti-inflammatory drugs, scleritis, episcleritis.

ABSTRACT

The inflammatory diseases of the sclera are uncommon. They involve both the sclera and the episclera and are characterized by chronic nature, pain and potential cause of blindness. Their association with systemic diseases, frequently autoimmune ones, and the occurrence of serious ocular complications lead to applying aggressive systemic therapy with non-steroid antinflammatory drugs, corticosteroids and immunosuppressive agents, which can be administered alone or combined. This is a 37 years-old patient who went to the emergency service because he suffered intense ocular pain associated to red eyes, reduction of visual acuity and high ocular pressure values in his right eye. He was finally diagnosed with posterior scleritis.


REFERENCES

  1. Benson WE. Posterior scleritis. Survey Ophthalmol. 1988;32(5):297-316.

  2. Whitcup SM. Scleritis. In: Nussenblatt RB, Whitcup SM, editors. Uveitis fundamental and clinical practice. Elsevier: Mosby; 2004. p. 287-90.

  3. Meyer PA, Watson PG, Franks W, Dubard P. Pulse inmunosupresive therapy in the treatment of inmunologically induced corneal and scleral disease. Eye. 1987;1:487-95.

  4. Watson PG. The nature and treatment of scleral inflammation. Trans Ophthalmol Soc UK. 1982;99:257.

  5. Vitale AT, Sainz de la Maza. Scleral Inflammatory Disease. In: Ryan SJ, editor. Retina. Elseiver: Mosby; 2006. p. 1731-46.

  6. Jabs DA. Episcleritis and scleritis: clinical features and treatment results. Am J Ophthalmol. 2000;10:469-76.

  7. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163-91.

  8. Mc Gavin DD, Williamson J. Episcleritis and scleritis: a study of their clinical manifestation and association with reumathoid arthritis. Br J Ophthalmol. 1976;60:192-226.

  9. Sainz de la Maza M. Severity of scleritis and episcleritis. Ophthalmology. 1994;101:389-96.

  10. Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology. 1991; 98:467-71.

  11. Mc Clusky PJ. Posterior scleritis: clinical features, systemis associations and outcome in a large series of patients. Ophthalmology. 1999;166:2380-6.

  12. Sainz de la Maza M, Foster CS. Scleritis associated with systemic vasculitis diseases. Ophthalmology. 1995;102:687-92.

  13. Karamursel E, Thorne J. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501-5.

  14. Fernández-Baca G, Losada Castillo MJ, Pérez Barreto L, Martin Barrera F. Escleritis asociadas a enfermedades sistémicas. Arch Soc Canar Oftal. 2005 [citado 16 de mayo de 2014]. Disponible en: http://www.oftalmo.com/sco/revista- 16/16sco17.htm




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Oftal. 2014;27